Clear Trail Advisors LLC Acquires 5,856 Shares in AbbVie Inc.

The institutional investor bought a new position in the pharmaceutical company's stock.

Mar. 24, 2026 at 8:37am

Got story updates? Submit your updates here. ›

Clear Trail Advisors LLC, an institutional investor, purchased 5,856 shares of AbbVie Inc. (NYSE:ABBV) during the fourth quarter, according to a recent SEC filing. The shares were valued at approximately $1,338,000. Several other large investors have also recently bought and sold shares of AbbVie.

Why it matters

AbbVie is a major pharmaceutical company with a diverse product portfolio and pipeline, making it an attractive investment for institutional investors like Clear Trail Advisors. This acquisition reflects the firm's confidence in AbbVie's long-term growth potential.

The details

According to the filing, Clear Trail Advisors LLC purchased 5,856 shares of AbbVie Inc. during the fourth quarter. The shares were valued at approximately $1,338,000. The filing also noted that several other large investors have recently bought and sold shares of AbbVie.

  • The shares were purchased during the fourth quarter.

The players

Clear Trail Advisors LLC

An institutional investor that purchased a new position in AbbVie Inc.

AbbVie Inc.

A global, research-driven biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and often chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

This acquisition by Clear Trail Advisors LLC reflects the continued interest and confidence in AbbVie's long-term growth potential among institutional investors, despite the company's recent stock price fluctuations.